Forum Alert: Aethlon Medical Presentation at Informed Investors Biotechnology & Healthcare Stocks Forum at the Crowne Plaza in Foster City on Tuesday, Dec. 7, 2004, 10:00 am PT.SAN DIEGO -- Aethlon Medical (OTCBB OTCBB See OTC Bulletin Board (OTCBB). : AEMD AEMD Automotive Electric Motor Drive (US Department of Energy program) ) will present at the following forum:
What: Informed Investors Biotechnology & Healthcare Stocks Forum
When: December 7, 2004 @ 10 AM Pacific Time
Where: The Crowne Plaza, 1221 Chess Dr., Foster City, CA 94404
How: To attend live event, pre-registration is necessary. To
register contact Cary Loeser, cloeser@wilink.com,
804-327-3407 or call Customer Service at 888-301-6618
Contact: James Joyce, Chief Executive Officer, jj@aethlonmedical.com
If you are unable to attend the live event, the forum will be available via webcast at http://www.informedinvestors.com/CustomEvent/85135/index.asp?ForumID= 85135. (Due to the length of this URL URL in full Uniform Resource Locator Address of a resource on the Internet. The resource can be any type of file stored on a server, such as a Web page, a text file, a graphics file, or an application program. , it may be necessary to copy and paste To copy files from one location to another or to copy text and images from one document to another. All modern operating systems and applications have a copy and paste capability that is typically selected from an Edit menu. See cut and paste and Win Copy between windows. this hyperlink into your Internet browser's URL address field.) Aethlon Medical is pioneering the development of viral filtration devices that rapidly reduce the presence of infectious disease and toxins in the body. Aethlon has published compelling human blood studies of the HemopurifierTM to treat HIV/AIDS HIV/AIDS Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome and Hepatitis-C (HCV HCV abbr. hepatitis C virus HCV 1 Hepatitis C virus, see there 2. Human coronavirus. See Coronavirus. ), and most recently, has announced that it is developing pathogen filtration devices to treat infectious agents used in biological warfare and terrorism. The Hemopurifier is a proprietary platform technology that converges the established scientific principles of affinity chromatography and hemodialysis as a means to augment the immune response of clearing viruses and toxins from the blood before cell and organ infection can occur. On March 4, 2004, Aethlon announced a cooperative agreement with the National Center for Biodefense (NCBD) at George Mason University Named after American revolutionary, patriot and founding father George Mason, the university was founded as a branch of the University of Virginia in 1957 and became an independent institution in 1972. . Under the agreement, Aethlon and the NCBD will collaborate to develop pathogen and toxin filtration devices designed to protect the lives of U.S. Military personnel exposed to infectious agents as a result of biological warfare. For additional information, visit the company's Web site at www.AethlonMedical.com. FORUM CONTACT: Cary Loeser, Informed Investors, 804-327-3407, cloeser@wilink.com Web site: http://www.informedinvestors.com |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion